#10,322 by institutional money · Stock
enGene Therapeutics Inc. (ENGNW)
Institutional ownership from Q3 2026 Form 13F filings
$0.16
−10.34% today
Market closed. Prices as of Nov 20, 7:11 AM ET
- 13F holders
- 11 (+1)
- Held by 13F filers, live
- $398K
- Shares held
- 2,469,302
- Share of stock outstanding
- n/a
- Net buying in Q3 2026
- +$1K
- New positions / sold out
- 2 / 1
Largest holders
11 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| BVF Inc/il | 945,402 | $152K | <0.1% | Unchanged |
| Blue Owl Capital Holdings LP | 511,177 | $82K | <0.1% | Unchanged |
| Caption Management, LLC | 333,675 | $54K | <0.1% | Unchanged |
| LMR Partners LLP | 309,763 | $50K | <0.1% | Unchanged |
| Aristeia Capital, L.l.c. | 197,678 | $32K | <0.1% | Unchanged |
| D. E. Shaw & Co., Inc. | 104,622 | $17K | <0.1% | Unchanged |
| Toronto Dominion Bank | 31,645 | $5K | <0.1% | Added +0% |
| CSS LLC/il | 16,895 | $3K | <0.1% | Unchanged |
| Susquehanna International Group, LLP | 16,801 | $3K | <0.1% | New |
| Wolverine Asset Management LLC | 1,344 | $217 | <0.1% | New |
| Clear Street Group Inc. | 300 | $48 | <0.1% | Added +50% |